Editorial response: hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors.
Brinkman
K
K
Onze Lieve Vrouwe Gasthuis, 1091 HA Amsterdam, Netherlands. k.brinkman@OLVG.nl
D000140:Acidosis, Lactic / Q000139:chemically induced* / Q000150:complications; D019380:Anti-HIV Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008107:Liver Diseases / Q000150:complications; D008930:Mitochondria, Liver / Q000187:drug effects*; D009705:Nucleosides / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
D019380:Anti-HIV Agents; D009705:Nucleosides; D018894:Reverse Transcriptase Inhibitors